Elevations of cardiac troponin (cTn), particularly cardiac troponin T (cTnT), are common in non-cardiac diseases and may complicate clinical decision making and potentially lead to unnecessary invasive procedures. The currently used commercial high-sensitivity cTnT (hs-cTnT) assay detects all circulating cTnT mol...
S. Knudsen, R. Hasselbalch, N. Strandkjær et al.· European Heart Journal· 0 citations
Cardiac troponins (cTn) are central to the diagnosis of acute coronary syndrome. Fulfilment of the criteria for myocardial injury (cTn>99th percentile) is common in non-cardiac diseases and cTn-release mechanisms remain incompletely understood. Cardiac troponin T (cTnT) release from skeletal muscle has been demon...
S. Knudsen, R. Hasselbalch, N. Strandkjær et al.· European Heart Journal· 0 citations
In patients with non-cardiac diseases, hs-cTnT elevations were significantly more prevalent than hs-cTnI elevations, suggesting distinct underlying mechanisms of myocardial injury and supporting a disease-specific of troponin elevations beyond ACS.
S. Knudsen, R. Hasselbalch, N. Strandkjær et al.· European Heart Journal· 0 citations
BACKGROUND
Ischemic heart disease (IHD) is the leading global cause of years of life lost. Although the clinical presentation and progression of IHD differ widely, clinical management is relatively uniform. To improve risk stratification and clinical management, we developed a decision support tool - the PMHeartIHD Alg...
A. Ringgaard, S. Rand, Chao-Qun Zheng et al.· American Heart Journal· 0 citations
The findings reinforce the role of echocardiographic screening of first-degree relatives and highlight the need for improved genetic discovery to enhance risk stratification in BAV.
J. Bruhn, J. Norsk, A. Sillesen et al.· European Heart Journal· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.